- Home
- JAGX vs TTOO Comparison
JAGX vs TTOO Comparison
Compare JAGX & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- TTOO
- Stock Information
- Founded
- JAGX 2013
- TTOO 2006
- Country
- JAGX United States
- TTOO United States
- Employees
- JAGX N/A
- TTOO N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- TTOO Medical/Dental Instruments
- Sector
- JAGX Health Care
- TTOO Health Care
- Exchange
- JAGX Nasdaq
- TTOO Nasdaq
- Market Cap
- JAGX 11.3M
- TTOO 10.7M
- IPO Year
- JAGX N/A
- TTOO 2014
- Fundamental
- Price
- JAGX $0.86
- TTOO $0.35
- Analyst Decision
- JAGX
- TTOO Hold
- Analyst Count
- JAGX 0
- TTOO 1
- Target Price
- JAGX N/A
- TTOO $5.00
- AVG Volume (30 Days)
- JAGX 505.4K
- TTOO 1.0M
- Earning Date
- JAGX 11-13-2024
- TTOO 02-13-2025
- Dividend Yield
- JAGX N/A
- TTOO N/A
- EPS Growth
- JAGX N/A
- TTOO N/A
- EPS
- JAGX N/A
- TTOO N/A
- Revenue
- JAGX $10,480,000.00
- TTOO $7,677,000.00
- Revenue This Year
- JAGX $32.33
- TTOO $50.31
- Revenue Next Year
- JAGX $43.63
- TTOO $117.92
- P/E Ratio
- JAGX N/A
- TTOO N/A
- Revenue Growth
- JAGX N/A
- TTOO N/A
- 52 Week Low
- JAGX $0.84
- TTOO $0.31
- 52 Week High
- JAGX $21.60
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- JAGX 40.81
- TTOO 23.45
- Support Level
- JAGX $0.84
- TTOO $0.31
- Resistance Level
- JAGX $1.29
- TTOO $0.55
- Average True Range (ATR)
- JAGX 0.09
- TTOO 0.06
- MACD
- JAGX -0.01
- TTOO 0.01
- Stochastic Oscillator
- JAGX 3.59
- TTOO 8.97
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.